isoflurane has been researched along with Angiogenesis, Pathologic in 2 studies
Isoflurane: A stable, non-explosive inhalation anesthetic, relatively free from significant side effects.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Metastatic recurrence of ovarian cancer is the foremost cause of postoperative mortality." | 1.42 | Impact of isoflurane on malignant capability of ovarian cancer in vitro. ( Hennah, L; Liu, J; Luo, X; Ma, D; Ning, J; Tu, H; Zhao, H, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sumi, C | 1 |
| Matsuo, Y | 1 |
| Kusunoki, M | 1 |
| Shoji, T | 1 |
| Uba, T | 1 |
| Iwai, T | 1 |
| Bono, H | 1 |
| Hirota, K | 1 |
| Luo, X | 1 |
| Zhao, H | 1 |
| Hennah, L | 1 |
| Ning, J | 1 |
| Liu, J | 1 |
| Tu, H | 1 |
| Ma, D | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Anesthesia and Immunological and Oxidative Stress in Relation to Abdominal Cancer Surgery[NCT03974984] | 0 participants (Actual) | Observational | 2020-06-04 | Withdrawn (stopped due to Not feasable due to logistics) | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 other studies available for isoflurane and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Cancerous phenotypes associated with hypoxia-inducible factors are not influenced by the volatile anesthetic isoflurane in renal cell carcinoma.
Topics: Anesthetics, Inhalation; Carcinoma, Renal Cell; Cell Movement; Cell Proliferation; Gene Expression R | 2019 |
Impact of isoflurane on malignant capability of ovarian cancer in vitro.
Topics: Anesthetics, Inhalation; Blotting, Western; Cell Division; Cell Movement; Cell Proliferation; Female | 2015 |